JAK inhibitor reduces pain for a long time

Patients with active rheumatoid arthritis often suffer from considerable pain. Therefore, pain control is an important treatment goal in this patient group. In a post-hoc analysis of the FINCH studies 1-3, the specific effects of the JAK1 inhibitor filgotinib on pain control and the relationship between efficacy and pain response were investigated.